a developer of particle-based vaccines and therapeutics for prevention and treatment of human disease
Industry Biotechnology
A.I.dvisor tells us that LQDA and FOLD have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LQDA and FOLD's prices will move in lockstep.
Ticker / NAME | Correlation To LQDA | 1D Price Change % | ||
---|---|---|---|---|
LQDA | 100% | -2.39% | ||
FOLD - LQDA | 27% Poorly correlated | -2.70% | ||
PCVX - LQDA | 26% Poorly correlated | -4.09% | ||
PLRX - LQDA | 25% Poorly correlated | -6.68% | ||
HOOK - LQDA | 25% Poorly correlated | -8.19% | ||
ALT - LQDA | 25% Poorly correlated | -11.19% | ||
More |
Ticker / NAME | Correlation To LQDA | 1D Price Change % |
---|---|---|
LQDA | 100% | -2.39% |
prevention theme (2 stocks) | 82% Closely correlated | -2.66% |
human theme (15 stocks) | 13% Poorly correlated | +2.16% |
therapeutics theme (53 stocks) | 10% Poorly correlated | -2.40% |
vaccines theme (15 stocks) | 10% Poorly correlated | -5.06% |
treatment theme (56 stocks) | 8% Poorly correlated | -1.02% |
More |